RGEN Q3 2017 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$37M+48.2% YoY

Gross Profit

$17M45.4% margin

Operating Income

-$406,000-1.1% margin

Net Income

$5M12.8% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+12.7%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$734M

Total Liabilities

$157M

Stockholders' Equity

$577M

Cash & Equivalents

$160M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$25M	+48.2%
Gross Profit	$17M	$13M	+23.5%
Operating Income	-$406,000	$4M	-110.8%
Net Income	$5M	$1M	+304.2%